Autologous Stem Cell Market Analysis by Type (Autologous Non-Stem Cells, Autologous Stem Cells), by Application (Cardiovascular Disease, Cancer, Neurodegenerative Disorders), by End User (Ambulatory Surgical Centers, Hospitals), and by Region - Forecast to 2029

Request Sample Page

The global autologous stem cell market size is estimated to be USD 3,99.9 million in 2021 and is expected to witness a CAGR of 3.98% during the forecast period. Rising global cases of targeted diseases is a key driver for the growth of the global autologous stem cell market. Additionally, introduction of new autologous stem cell centered therapies in regenerative medicine and increase in global geriatric population are some of the other drivers propelling the market growth. Nevertheless, high rate of autologous cellular therapies and lack of knowledge regarding autologous stem cell research among developing economies are expected to restrain the global market growth.

Global Autologous Stem Cell Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is segmented into autologous non-stem cells and autologous stem cells. In 2021, the autologous stem cells segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to this segment gaining approval from initiatives taken by several governments worldwide. Autologous non-stem cells segment is expected to grow at a profitable CAGR during the forecast period. This is attributed to the fact that it is increasingly being used as a major treatment for many incurable diseases such as ischemic heart failure, Myocardial infarction, diabetes.

By Application

Based on application, the market is segmented into cardiovascular diseases, cancer, orthopedic diseases, neurodegenerative disorders, and others. In 2021, the cancer segment accounted for the substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is attributed to the growing incidence and prevalence of cancer worldwide. Neurodegenerative disorders segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to the growth in investment in R&D activities for new product development in this segment.

By End User

Based on end user, the market is categorized into ambulatory surgical centers, hospitals, and research facilities. In 2021, the hospitals segment accounted for a substantial revenue share and it anticipated to grow with a lucrative CAGR during the forecast period. This is due to the large target patient population base preferring hospitals, increasing emphasis on effective and early disease diagnosis in hospital worldwide. The ambulatory surgical centers segment is anticipated to grow at a profitable CAGR during the forecast period, due to the ability to conduct wide-ranging number of tests by using autologous stem cells in the ambulatory surgical centers.

Regional Insights

In 2021, North America held the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, rise in incidence of chronic diseases such as blood disorders, cancer, autoimmune diseases, and growth in initiatives from the government, and accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and introduction of new therapies in the market.

Competitor Insights

Some of the key players in the autologous stem cell market are Antria (CRO) (U.S.); Bioheart (U.S.); Brainstorm Cell Therapeutics (U.S.); Cytori (U.S.); Dendreon Corporation (U.S.); Fibrocell (U.S.); Genesis Biopharma (U.S.); Georgia Health Sciences University (U.S.); Regeneus (Australia); and Opexa Therapeutics (U.S.). The leading players operating in the autologous stem cell industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The autologous stem cell market report is categorized into the following segments and subsegments:

Autologous Stem Cell Market, By Type (Revenue, USD Million, 2021 – 2029)

  • Autologous Non-Stem cells
  • Autologous Stem Cells

Autologous Stem Cell Market, By Application (Revenue, USD Million, 2021 – 2029)

  • Cardiovascular Disease
  • Cancer
  • Orthopedic Diseases
  • Neurodegenerative Disorders
  • Others

Autologous Stem Cell Market, By End User (Revenue, USD Million, 2021 – 2029)

  • Ambulatory Surgical Centers
  • Hospitals
  • Research Facilities

Autologous Stem Cell Market, By Region (Revenue, USD Million, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

Scope of Autologous Stem Cell Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Autologous Stem Cell Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Autologous Stem Cell
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Autologous Stem Cell Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Source
    1. Bone Marrow
      1. Bone Marrow Market Forecast, 2021-2029 (USD Million)
    2. Hematopoietic Stem Cells
      1. Hematopoietic Stem Cells Market Forecast, 2021-2029 (USD Million)
    3. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Wound Healing
      1. Wound Healing Market Forecast, 2021-2029 (USD Million)
    2. Neurological Disorders
      1. Neurological DisordersMarket Forecast, 2021-2029 (USD Million)
    3. Orthopedic Disorders
  1. Orthopedic Disorders Market Forecast, 2021-2029 (USD Million)
  1. Cancer
    1. Cancer Market Forecast, 2021-2029 (USD Million)
  2. Autoimmune Disorders
    1. Autoimmune Disorders Market Forecast, 2021-2029 (USD Million)
  3. Others
    1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by End user
    1. Research Centers
      1. Research Centers Market Forecast, 2021-2029 (USD Million)
    2. Hospitals
      1. Hospitals Market Forecast, 2021-2029 (USD Million)
    3. Ambulatory Surgical Centers
      1. Ambulatory Surgical Centers Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Autologous Stem Cell Market
    1. North America Autologous Stem Cell Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Source, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. S. Autologous Stem Cell Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Source, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. Canada Autologous Stem Cell Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Source, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Europe Autologous Stem Cell Market
    1. Europe Autologous Stem Cell Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Source, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. Germany Autologous Stem Cell Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Source, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. UK Autologous Stem Cell Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Source, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. France Autologous Stem Cell Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Source, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End user, 2021-2029 (USD Million)
            2. Spain Autologous Stem Cell Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by End user, 2021-2029 (USD Million)
              2. Italy Autologous Stem Cell Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by End user, 2021-2029 (USD Million)
                2. Rest of Europe Autologous Stem Cell Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Asia Pacific Autologous Stem Cell Market
    1. Asia Pacific Autologous Stem Cell Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Source, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. Japan Autologous Stem Cell Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Source, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. China Autologous Stem Cell Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Source, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. India Autologous Stem Cell Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Source, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End user, 2021-2029 (USD Million)
            2. South Korea Autologous Stem Cell Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by End user, 2021-2029 (USD Million)
              2. Australia Autologous Stem Cell Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by End user, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Autologous Stem Cell Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Latin America Autologous Stem Cell Market
    1. Latin America Autologous Stem Cell Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Source, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. Brazil Autologous Stem Cell Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Source, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. Mexico Autologous Stem Cell Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Source, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. Argentina Autologous Stem Cell Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Source, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End user, 2021-2029 (USD Million)
            2. Rest of Latin America Autologous Stem Cell Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Source, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. MEA Autologous Stem Cell Market
    1. MEA Autologous Stem Cell Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Source, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End user, 2021-2029 (USD Million)
      2. GCC Autologous Stem Cell Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Source, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End user, 2021-2029 (USD Million)
        2. South Africa Autologous Stem Cell Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Source, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End user, 2021-2029 (USD Million)
          2. Rest of MEA Autologous Stem Cell Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Source, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End user, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Athersys (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    2. Mesoblast (Australia)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    3. BioRestorative Therapies (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    4. Pluristem Therapeutics (Israel)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    5. BrainStorm Cell Therapeutics (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    6. ViaCyte (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    7. Kangstem Biotech (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    8. Hope Biosciences (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    9. Cellular Biomedicine Group (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    10. Smith & Nephew (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    11. MEDIPOST (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Source Benchmarking
      5. Recent Developments
    12. Anterogen (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Source Benchmarking
      5. Recent Developments
    13. CORESTEM (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Source Benchmarking
      5. Recent Developments
    14. PHARMICELL (South Korea)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Source Benchmarking
      5. Recent Developments
    15. RTI Surgical (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Source Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports